STOCK TITAN

Veeva Systems Inc. - VEEV STOCK NEWS

Welcome to our dedicated page for Veeva Systems news (Ticker: VEEV), a resource for investors and traders seeking the latest updates and insights on Veeva Systems stock.

Veeva Systems Inc. (NYSE: VEEV) is a global leader in cloud-based software solutions specifically tailored for the life sciences industry. Headquartered in the San Francisco Bay Area, Veeva Systems provides innovative technology that helps pharmaceutical and biotech companies streamline their operations, ensure compliance, and bring products to market faster. Veeva's product offerings address key operational and regulatory needs, ranging from customer relationship management (CRM) to content management and data analytics.

Two of the company's flagship products include Veeva CRM and Veeva Vault. Veeva CRM is designed for companies with a salesforce, providing tools to manage customer interactions more efficiently. Meanwhile, Veeva Vault is a versatile content management platform that supports various functions such as clinical trials, regulatory submissions, and quality management within life sciences companies.

Veeva serves a diverse customer base, ranging from emerging biotechs to some of the world's largest pharmaceutical companies. Its commitment to product excellence, customer success, and continuous innovation is evident as Veeva frequently updates its offerings to meet the evolving needs of the industry. Recently, Veeva announced that Boehringer Ingelheim has selected Veeva Vault Clinical and Veeva Vault RIM applications to streamline clinical execution and improve regulatory management in its animal health business unit.

Another notable achievement for Veeva was the launch of the Veeva AI Partner Program, designed to help partners integrate Generative AI solutions seamlessly with Veeva Vault applications. This initiative highlights Veeva's ongoing efforts to leverage advanced technologies to enhance its product ecosystem. Furthermore, the introduction of Veeva Vault CRM Campaign Manager aims to simplify and speed up non-personal promotion to healthcare professionals, ensuring consistent and compliant marketing efforts.

Financially, Veeva Systems has shown strong performance with its fiscal year 2024 results reflecting robust growth. The company continues to invest in its innovation engine and strategic partnerships, setting the stage for sustained, profitable growth. Veeva's recent financial outlook for fiscal year 2025 and first quarter results for 2024 further underline its market leadership and operational excellence.

For more information about Veeva Systems, its products, and latest updates, visit www.veeva.com.

Rhea-AI Summary
Veeva Systems (NYSE: VEEV) will announce financial results for its fourth quarter and full fiscal year on February 29, 2024. The company will host a conference call and webcast to discuss its financial results. Prepared remarks will be posted to its investor relations website. Investors and analysts can register for the conference call and access the webcast replay on the company's website.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
2.5%
Tags
-
Rhea-AI Summary
Veeva Systems (NYSE: VEEV) has announced the availability of the full Veeva Compass Suite of commercial data products, including Compass Prescriber and Compass National, providing projections for both retail prescriptions and complex procedures. The suite also includes Compass Patient, offering granular, longitudinal patient data. The products are licensed by the brand and give unlimited data access, including historical data. The availability of the full Veeva Compass Suite of data products is a significant milestone for the industry and Veeva, delivering innovations in commercial data for life sciences.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-1.18%
Tags
none
-
Rhea-AI Summary
Veeva Systems (NYSE: VEEV) announced that over 350 companies are using its training solutions to modernize employee qualification processes, with a focus on GxP training. The solutions help prevent quality deficiencies, job-related errors, and audit failures, while also improving job performance and ensuring inspection readiness.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
1.29%
Tags
none
Rhea-AI Summary
Veeva Systems (VEEV) announced that a top 20 biopharma and Veeva Services migrated 25 ongoing clinical studies to Veeva Vault EDC from a legacy electronic data capture application. This successful migration is an industry first and includes a large study with over 500 research sites and 7,000 patients. The customer plans to use Vault EDC for all current and future trials globally. The migration was enabled by Vault EDC's proprietary capability to migrate ongoing studies securely with minimal disruption, addressing concerns about technical challenges and complex data models. This capability allows customers to decommission legacy EDC systems while advancing clinical data management.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-2.57%
Tags
none
-
Rhea-AI Summary
Veeva Systems (NYSE: VEEV) is set to participate in the 26th Annual Needham Growth Conference with Brent Bowman, CFO, and Paul Shawah, EVP Commercial Strategy, presenting on January 19, 2024. The presentation will be webcasted, and links will be available on Veeva's investor relations website.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-2.57%
Tags
conferences
-
Rhea-AI Summary
SK Life Science, Inc. (NYSE: VEEV) adopts Veeva Vault Validation Management to streamline and accelerate their validation process, improving efficiency, data integrity, and audit readiness. The company aims to modernize validation for greater efficiency and speed, driving greater compliance and traceability across all systems.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
5.33%
Tags
none
Rhea-AI Summary
Veeva Systems (NYSE: VEEV) CEO to Present at 42nd Annual J.P. Morgan Healthcare Conference
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
2.61%
Tags
conferences
-
Rhea-AI Summary
Recipharm (NYSE: RECI) to Standardize Quality Operations with Veeva Vault QMS, QualityDocs, and Training
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
0.74%
Tags
none
-
Rhea-AI Summary
Veeva Systems Inc. (NYSE: VEEV) reported total revenues of $616.5M, up 12% year over year, with subscription services revenues of $494.9M, also up 12% year over year. Operating income was $128.5M, a 6% increase, and non-GAAP net income was $218.7M, a 19% increase. The company announced significant commercial and data platform innovations, positioning itself for profitable growth.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-3.05%
Tags
Rhea-AI Summary
Veeva Systems (VEEV) announced that GSK will be one of the first top biopharma companies to migrate to Veeva Vault CRM, aiming to positively impact 2.5 billion people by the end of 2030. The adoption of the next generation CRM for life sciences will enable GSK to interact with customers based on their needs and in ways that work best for them, leading to more effective healthcare professional engagement. GSK's senior vice president of commercial and digital technology, Kieron Scrutton, emphasized the importance of data and technology in achieving GSK's goals, stating that moving to Vault CRM is a clear next step for the company. Veeva's president and chief operating officer, Tom Schwenger, highlighted the trusted partnership between GSK and Veeva, expressing confidence in GSK's forward-thinking approach to customer relationships by taking full advantage of Vault CRM and future innovations.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-1.83%
Tags
none

FAQ

What is the current stock price of Veeva Systems (VEEV)?

The current stock price of Veeva Systems (VEEV) is $217.43 as of December 24, 2024.

What is the market cap of Veeva Systems (VEEV)?

The market cap of Veeva Systems (VEEV) is approximately 35.3B.

What does Veeva Systems Inc. do?

Veeva Systems Inc. provides cloud-based software solutions for the global life sciences industry, including tools for CRM, content management, and data analytics.

Where is Veeva Systems Inc. headquartered?

Veeva Systems Inc. is headquartered in the San Francisco Bay Area.

What are Veeva's main products?

Veeva's main products include Veeva CRM, a customer relationship management platform, and Veeva Vault, a content management platform.

Who are Veeva Systems' customers?

Veeva Systems serves over 1,000 customers, ranging from the world's largest pharmaceutical companies to emerging biotechs.

What recent partnerships has Veeva announced?

Recently, Veeva announced a partnership with Boehringer Ingelheim, which selected Veeva Vault Clinical and Veeva Vault RIM for its animal health business unit.

What is the Veeva AI Partner Program?

The Veeva AI Partner Program provides partners with technology and support to integrate Generative AI solutions seamlessly with Veeva Vault applications.

How has Veeva performed financially recently?

Veeva has reported strong financial results for fiscal year 2024 and continues to show robust growth and operational excellence.

What is Veeva Vault CRM Campaign Manager?

Veeva Vault CRM Campaign Manager is a new marketing application that simplifies and speeds non-personal promotion to healthcare professionals, ensuring consistency and compliance.

What industry does Veeva Systems primarily serve?

Veeva Systems primarily serves the life sciences industry.

How does Veeva contribute to the life sciences industry?

Veeva helps life sciences companies streamline operations, ensure compliance, and bring products to market faster through its innovative cloud-based software solutions.

Veeva Systems Inc.

NYSE:VEEV

VEEV Rankings

VEEV Stock Data

35.30B
147.87M
8.94%
83.88%
1.45%
Health Information Services
Services-prepackaged Software
Link
United States of America
PLEASANTON